Tiziana Claudia Aranzulla | Interventional Cardiology | Best Researcher Award

Published on by AI Data Scientist

Prof. Dr. Tiziana Claudia Aranzulla | Interventional Cardiology | Best Researcher Award

Interventional Cardiologist at Hospital Trust of the Mauriziano Order of Turin, Italy

Tiziana Claudia Aranzulla is an esteemed interventional cardiologist with extensive experience in complex percutaneous coronary interventions and structural heart procedures. Since 2008, she has been serving as a senior cardiologist at the Azienda Ospedaliera Ordine Mauriziano di Torino in Italy. Recognized for her dedication to clinical excellence and education, she is known for mentoring residents and fellows and contributing significantly to cardiovascular research. Her clinical work integrates advanced imaging techniques and innovative therapies, reinforcing her leadership in interventional cardiology. Dr. Aranzulla’s commitment to improving patient outcomes and expanding gender representation in cardiology has earned her national and international acclaim.

Profile

Orcid

Education

Dr. Aranzulla’s academic path began with a degree in Medicine and Surgery from the University of Bologna, earned with highest honors (110/110 cum laude) in 2000. She was certified by the medical board in June 2001, and her postgraduate specialization in Cardiology (2002–2005) was completed at the University “Vita-Salute” San Raffaele, Milan, with distinction. Furthering her clinical expertise, she pursued a Master’s in Interventional Cardiology in 2005–2006 at the same university under the guidance of notable experts including Dr. Antonio Colombo and Professor Attilio Maseri. Her early educational foundations also include a technical-commercial diploma and a classical high school diploma, both completed with outstanding academic performance.

Experience

Dr. Aranzulla has built a progressive and diversified career in clinical cardiology. She began as a consultant in emergency cardiology at San Raffaele Hospital and EMO Centro Cuore Columbus in Milan from 2005 to 2007, expanding her practice as an interventional cardiologist from 2006. She later served at ASL2 Savonese before securing her long-standing position in Turin. Her responsibilities include performing complex coronary procedures, supervising junior physicians, and managing acute and elective cardiac cases. She is also deeply involved in research development, protocol drafting, and ethical submissions. International experiences during her early career in the UK, Finland, Brazil, and Estonia provided her with multicultural perspectives and broadened her clinical insight.

Research Interest

Her research primarily focuses on interventional strategies for coronary artery disease, including treatment in diabetic patients, complex lesion management, and structural heart interventions like MitraClip and TAVI. A significant part of her academic pursuit includes the use of drug-eluting stents and the impact of gender in cardiovascular outcomes. She is especially noted for her interest in risk stratification for acute coronary syndromes and myocardial infarction in different demographic subsets. As an editorial reviewer and scientific committee member, she continues to support high-quality cardiovascular research dissemination and development.

Award

Dr. Aranzulla has been the recipient of numerous prestigious awards. These include the GISE Best Clinical Case Award (2019), the National “Comitato dei Cento” Award (2018), and the Albert Nelson Marquis Lifetime Achievement Award (2018). Her work has been consistently recognized at GISE, where she won various STEMI clinical case challenges from 2013 to 2018. She was also among the top ten women in interventional cardiology selected at the C3 conference in 2018. Other honors include best young researcher by ANMCO in 2013 and accolades from Medtronic and TRIS Live Case Quiz contests. She is a regular expert contributor on national television and has participated in numerous international congresses.

Publication

Dr. Tiziana Claudia Aranzulla has actively contributed to peer-reviewed literature in interventional cardiology, with multiple publications in high-impact journals. Her most recent article, “Arterial Gas Embolism During Mitral Transcatheter Edge‐to‐Edge Repair: Prevention, Management, and Treatment: Case Report and Review of the Literature”, published in Catheterization and Cardiovascular Interventions in May 2025 (DOI: 10.1002/ccd.31600), provides a critical case review on a rare but serious complication and has already attracted scholarly attention. In 2023, she co-authored “Nothing to do does not mean any consequences” in the same journal (DOI: 10.1002/ccd.30543), discussing nuanced procedural risks and outcomes in complex interventional settings. Her 2021 publication titled “Tobacco and Venus may reduce man to ashes, even when Bacchus is on vacation” (DOI: 10.1002/ccd.29997) reflects her commitment to creatively communicating medical insights within the framework of evidence-based practice. She also contributed to the study design of “CARotid plaqUe StabilizatiOn and regression with evolocumab: Rationale and design of the CARUSO study” in July 2021 (DOI: 10.1002/ccd.29743), a significant contribution toward understanding lipid-lowering therapies in plaque stabilization. Another impactful article, “Clipping mitral valve or atrial fibrillation? Two is better than one!”, published in May 2021 (DOI: 10.1002/ccd.29727), highlights procedural synergy in structural heart interventions. In the same year, her work “Morphological stabilization and regression of carotid plaque following therapy with evolocumab in a high‐risk patient” (DOI: 10.1002/ccd.29231) offered a compelling case for intensive lipid therapy, and her March 2021 article “Get it, bring it, and place it: Power is nothing without control” (DOI: 10.1002/ccd.29576) showcased advanced procedural techniques and control dynamics in complex PCI. These publications, collectively cited by multiple peer-reviewed articles, underscore her deep engagement with both clinical innovation and the broader cardiology research community.

Conclusion

Dr. Tiziana Claudia Aranzulla’s contributions to interventional cardiology span clinical innovation, academic leadership, and medical education. Her integration of advanced technologies with patient-centric care underscores her commitment to excellence. Beyond the catheterization lab, she actively participates in scientific societies, national committees, and international collaborations, positioning herself as a key figure in shaping the future of cardiovascular medicine. Her work, enriched by global exposure and reinforced by prestigious accolades, continues to influence and inspire both peers and the next generation of cardiologists.

Irene Ruengkhachorn | Medicine | Women Researcher Award

Published on by AI Data Scientist

Assoc. Prof. Dr. Irene Ruengkhachorn | Medicine | Women Researcher Award

Associate Professor at Faculty of Meidicine Siriraj Hospital, Mahidol university, Thailand

Dr. Irene Ruengkhachorn is a dedicated academic and clinical specialist in gynecologic oncology, currently serving as an Associate Professor at the Faculty of Medicine Siriraj Hospital, Mahidol University. With nearly two decades of medical and teaching experience, she has significantly contributed to the field through research, clinical practice, and education. Dr. Ruengkhachorn’s expertise spans minimally invasive surgery, integrative oncology, and advanced gynecologic cancer treatment protocols. Her scholarly activities have earned her recognition within the national and international medical community, where she continues to drive progress in women’s cancer care.

Profile

Orcid

Education

Dr. Ruengkhachorn has pursued a thorough and distinguished academic journey. She earned her Doctor of Medicine degree from the Faculty of Medicine Siriraj Hospital, Mahidol University, in 2000. She continued her postgraduate training at the same institution, completing graduate diplomas in Basic and Clinical Sciences in 2004 and 2005, respectively. She further specialized by earning a Thai Board certification in Obstetrics and Gynecology in 2006, and in Gynecologic Oncology from Chiangmai University in 2008. Her interest in surgical techniques led her to complete certifications in gynecologic laparoscopic surgery in 2012 and undergo visiting clinical training in minimally invasive surgery at Mayo Clinic, USA, the same year. In 2017, she added a Certificate of Advanced Medical Epidemiology from Thammasat University, equipping her with robust research design and analysis capabilities.

Experience

Dr. Ruengkhachorn began her academic career as an Instructor in 2009 at Siriraj Hospital, advancing to Assistant Professor in 2013 and later to Associate Professor in 2016. Over the years, she has played a central role in mentoring medical students and residents, particularly in gynecologic oncology rotations. Prior to her tenure at Siriraj Hospital, she also served as a tutor in the Gynecologic Oncology Department at Chiangmai University. Her long-standing service in one of Thailand’s leading tertiary care centers has enabled her to influence treatment protocols and participate in numerous multi-disciplinary teams that shape national cancer care standards.

Research Interest

Dr. Ruengkhachorn’s research interests are grounded in the clinical challenges of gynecologic oncology. She focuses on cervical and ovarian cancer management, outcomes of surgical interventions, and predictive biomarkers. Her work extends into evaluating oncologic outcomes, the role of pathology in treatment planning, and recently, integrating artificial intelligence and precision medicine approaches. She has also explored minimally invasive surgical techniques, HPV-related cytological abnormalities, and the role of traditional medicine in cancer care. Her aim is to translate clinical findings into practice guidelines that improve survival and quality of life for women affected by reproductive cancers.

Award

Her research has received multiple accolades that highlight both scientific rigor and relevance. In 2008, she won the GSK Research Award for her work on predicting the need for adjuvant radiotherapy in early-stage cervical cancer. The R2R Research Award followed in 2014, recognizing her investigation into atypical glandular cells in cytology. In 2017, she earned the “Research of the Month” title at Siriraj Hospital for her landmark study on outcomes of advanced cervical carcinoma treated with chemotherapy at a tertiary referral center. These honors underscore her contributions to evidence-based gynecologic oncology in high-incidence settings.

Publication

Dr. Ruengkhachorn has published extensively in peer-reviewed journals. Seven representative publications include:

  1. Ruengkhachorn I et al., “Oncologic outcomes of stage IVB or persistent or recurrent cervical carcinoma patients treated with chemotherapy,” Int J Gynecol Cancer, 2016, cited 49 times.

  2. Ittiamornlert P, Ruengkhachorn I, “Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes,” BMC Cancer, 2019, cited 61 times.

  3. Ruengkhachorn I et al., “Undiagnosed uterine sarcomas identified during surgery for presumed leiomyoma,” Int J Gynecol Cancer, 2017, cited 34 times.

  4. Ruengkhachorn I et al., “Comparison of oncologic outcomes of unanticipated cervical carcinoma,” Gynecol Oncol, 2019, cited 57 times.

  5. Phianpiset R, Ruengkhachorn I et al., “ASCCP risk-based colposcopy recommendations in Thai women,” Obstet Gynecol, 2020, cited 66 times.

  6. Ruengkhachorn I et al., “Predicting factors associated with resistance to Methotrexate in GTN,” Asian Pac J Clin Oncol, 2022, cited 23 times.

  7. Ruengkhachorn I et al., “High-risk HPV genotyping in atypical squamous cells,” Scientific Reports, 2023, cited 15 times.
    These publications reflect her diverse yet focused contributions in clinical oncology and diagnostic advancement.

Conclusion

Dr. Irene Ruengkhachorn has emerged as a leader in gynecologic oncology in Thailand through her relentless pursuit of clinical excellence, academic advancement, and translational research. Her academic path, enriched by international exposure and cross-disciplinary integration, positions her at the forefront of modern cancer care. As she continues to mentor young physicians, publish impactful research, and lead clinical innovation, Dr. Ruengkhachorn exemplifies the synergy of research and compassionate care in advancing women’s health. Her ongoing engagement with global research communities ensures her contributions remain both relevant and far-reaching in the evolving field of gynecologic oncology.